Drug Candidate for neurofibromatosis type 1-cutaneous neurofibroma (Healx)

N/A

Report date: 2025/01/26 17:59:26
NME

Base Information

Drug NameDrug Candidate for neurofibromatosis type 1-cutaneous neurofibroma (Healx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurofibromatosis 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHealx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHealx Ltd
Inactive CompaniesN/A
Active IndicationsNeurofibromatosis 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A